• Passa alla navigazione primaria
  • Passa al contenuto principale
BC

biochimica clinica

it_IT Italian
it_IT Italian en_US English

OPINIONI - Opinions

Volume:

Biochimica Clinica 2020; 44(4) 001-002

Pubblicato on-line:

Maggio 18, 2020

DOI:

10.19186/BC_2020.053

Scarica in PDF:

Il valore della medicina di laboratorio nella pandemia da SARS-CoV-2
The value of laboratory medicine in SARS-CoV-2 outbreak

AUTORI

Mario Plebani
Dipartimento Medicina di Laboratorio, Azienda Ospedale-Università di Padova

ABSTRACT

The value of laboratory medicine in SARS-CoV-2 outbreak

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) represents a challenge to all heathcare systems. It represents, however, a formidabile opportunity to highlight the value of laboratory medicine. Laboratory tests, in fact, play a key role in allowing the etiological diagnosis thanks to the reverse transcription-plymerase chain reaction (rRT-PCR) to detect the virus in nasopharingeal specimes as well as in other samples collected by using a flocked swab. The second essential contribution that laboratory tests are providing encompasses staging, prognostication and therapeutic monitoring of COVID-19. Finally, serological tests play a central role for surveillance purposes, for using plasma containing antibodies from recovered patients as experimental treatment and for better understanding the immune response to SARS-CoV-2 to eventually address vaccine developments.

BIBLIOGRAFIA